vs
MESA LABORATORIES INC（MLAB）とVia Renewables, Inc.（VIASP）の財務データ比較。上の社名をクリックして会社を切り替えられます
Via Renewables, Inc.の直近四半期売上が大きい（$127.8M vs $65.1M、MESA LABORATORIES INCの約2.0倍）。MESA LABORATORIES INCの純利益率が高く（5.6% vs 5.4%、差は0.2%）。Via Renewables, Inc.の前年同期比売上増加率が高い（22.5% vs 3.6%）。MESA LABORATORIES INCの直近四半期フリーキャッシュフローが多い（$18.0M vs $-4.8M）。過去8四半期でVia Renewables, Inc.の売上複合成長率が高い（5.9% vs 5.1%）
メサラボラトリーズ社は、品質管理、校正、モニタリング向け専門機器及び関連サービスの開発・製造・販売を事業としています。医療、製薬、食品飲料、産業衛生、環境試験分野を中心に、世界中の顧客の規制遵守と運用安全のニーズに応えています。
EDFパワーソリューションズはフランスの公益事業者であるEDFグループの完全子会社で、再生可能エネルギー発電事業を専門としています。統合オペレーターとして同グループは再生可能エネルギー施設の開発・建設融資を行い、自社および第三者向けに運用・保守業務を提供しています。
MLAB vs VIASP — 直接比較
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $65.1M | $127.8M |
| 純利益 | $3.6M | $6.9M |
| 粗利率 | 64.2% | 34.4% |
| 営業利益率 | 12.2% | 15.2% |
| 純利益率 | 5.6% | 5.4% |
| 売上前年比 | 3.6% | 22.5% |
| 純利益前年比 | 316.6% | -30.9% |
| EPS（希薄化後） | $0.65 | $1.19 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $65.1M | $127.8M | ||
| Q3 25 | $60.7M | $103.3M | ||
| Q2 25 | $59.5M | $90.0M | ||
| Q1 25 | $62.1M | $142.3M | ||
| Q4 24 | $62.8M | $104.3M | ||
| Q3 24 | $57.8M | $93.8M | ||
| Q2 24 | $58.2M | $86.7M | ||
| Q1 24 | $58.9M | $114.1M |
| Q4 25 | $3.6M | $6.9M | ||
| Q3 25 | $2.5M | $757.0K | ||
| Q2 25 | $4.7M | $2.7M | ||
| Q1 25 | $-7.1M | $8.8M | ||
| Q4 24 | $-1.7M | $9.9M | ||
| Q3 24 | $3.4M | $2.1M | ||
| Q2 24 | $3.4M | $7.6M | ||
| Q1 24 | $-254.6M | $8.6M |
| Q4 25 | 64.2% | 34.4% | ||
| Q3 25 | 61.5% | 23.1% | ||
| Q2 25 | 62.0% | 30.0% | ||
| Q1 25 | 61.8% | 32.9% | ||
| Q4 24 | 63.3% | 51.9% | ||
| Q3 24 | 61.3% | 26.8% | ||
| Q2 24 | 64.0% | 50.4% | ||
| Q1 24 | 62.1% | 39.5% |
| Q4 25 | 12.2% | 15.2% | ||
| Q3 25 | 7.8% | 3.1% | ||
| Q2 25 | 5.1% | 6.7% | ||
| Q1 25 | 2.4% | 17.5% | ||
| Q4 24 | 9.2% | 31.5% | ||
| Q3 24 | 6.1% | 5.3% | ||
| Q2 24 | 9.6% | 23.8% | ||
| Q1 24 | -460.6% | 22.6% |
| Q4 25 | 5.6% | 5.4% | ||
| Q3 25 | 4.1% | 0.7% | ||
| Q2 25 | 8.0% | 3.0% | ||
| Q1 25 | -11.4% | 6.2% | ||
| Q4 24 | -2.7% | 9.5% | ||
| Q3 24 | 5.9% | 2.3% | ||
| Q2 24 | 5.8% | 8.8% | ||
| Q1 24 | -432.2% | 7.5% |
| Q4 25 | $0.65 | $1.19 | ||
| Q3 25 | $0.45 | $-0.41 | ||
| Q2 25 | $0.85 | $0.09 | ||
| Q1 25 | $-1.30 | $1.83 | ||
| Q4 24 | $-0.31 | $2.33 | ||
| Q3 24 | $0.63 | $-0.17 | ||
| Q2 24 | $0.62 | $1.51 | ||
| Q1 24 | $-47.26 | $1.81 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $29.0M | $41.8M |
| 総負債低いほど良い | $68.4M | $120.0M |
| 株主資本純資産 | $186.7M | $67.7M |
| 総資産 | $434.8M | $331.3M |
| 負債/資本比率低いほどレバレッジが低い | 0.37× | 1.77× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $29.0M | $41.8M | ||
| Q3 25 | $20.4M | $53.6M | ||
| Q2 25 | $21.3M | $62.1M | ||
| Q1 25 | $27.3M | $64.7M | ||
| Q4 24 | $27.3M | $53.1M | ||
| Q3 24 | $24.3M | $66.6M | ||
| Q2 24 | $28.5M | $53.6M | ||
| Q1 24 | $28.2M | $50.4M |
| Q4 25 | $68.4M | $120.0M | ||
| Q3 25 | $69.4M | $105.0M | ||
| Q2 25 | $70.3M | $100.0M | ||
| Q1 25 | $71.3M | $101.0M | ||
| Q4 24 | $72.2M | $106.0M | ||
| Q3 24 | $73.1M | $89.0M | ||
| Q2 24 | $74.1M | $93.0M | ||
| Q1 24 | — | $91.0M |
| Q4 25 | $186.7M | $67.7M | ||
| Q3 25 | $178.5M | $63.7M | ||
| Q2 25 | $172.5M | $68.2M | ||
| Q1 25 | $159.8M | $72.7M | ||
| Q4 24 | $155.2M | $66.7M | ||
| Q3 24 | $161.5M | $58.2M | ||
| Q2 24 | $150.7M | $58.3M | ||
| Q1 24 | $145.4M | $53.2M |
| Q4 25 | $434.8M | $331.3M | ||
| Q3 25 | $430.4M | $304.8M | ||
| Q2 25 | $435.7M | $316.3M | ||
| Q1 25 | $433.3M | $347.4M | ||
| Q4 24 | $433.3M | $344.9M | ||
| Q3 24 | $454.1M | $298.4M | ||
| Q2 24 | $440.4M | $299.7M | ||
| Q1 24 | $446.8M | $302.7M |
| Q4 25 | 0.37× | 1.77× | ||
| Q3 25 | 0.39× | 1.65× | ||
| Q2 25 | 0.41× | 1.47× | ||
| Q1 25 | 0.45× | 1.39× | ||
| Q4 24 | 0.47× | 1.59× | ||
| Q3 24 | 0.45× | 1.53× | ||
| Q2 24 | 0.49× | 1.60× | ||
| Q1 24 | — | 1.71× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $18.8M | $-4.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $18.0M | $-4.8M |
| FCFマージンFCF / 売上 | 27.7% | -3.7% |
| 設備投資強度設備投資 / 売上 | 1.1% | 0.4% |
| キャッシュ転換率営業CF / 純利益 | 5.17× | -0.61× |
| 直近12ヶ月FCF直近4四半期 | $37.9M | $39.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $18.8M | $-4.2M | ||
| Q3 25 | $8.2M | $2.4M | ||
| Q2 25 | $1.9M | $19.0M | ||
| Q1 25 | $12.7M | $24.9M | ||
| Q4 24 | $18.1M | $2.0M | ||
| Q3 24 | $5.3M | $20.1M | ||
| Q2 24 | $10.7M | $11.2M | ||
| Q1 24 | $12.9M | $17.1M |
| Q4 25 | $18.0M | $-4.8M | ||
| Q3 25 | $7.1M | $1.9M | ||
| Q2 25 | $884.0K | $18.4M | ||
| Q1 25 | $11.9M | $23.5M | ||
| Q4 24 | $17.3M | $1.6M | ||
| Q3 24 | $3.5M | $19.7M | ||
| Q2 24 | $9.9M | $10.9M | ||
| Q1 24 | $12.3M | $16.6M |
| Q4 25 | 27.7% | -3.7% | ||
| Q3 25 | 11.7% | 1.9% | ||
| Q2 25 | 1.5% | 20.5% | ||
| Q1 25 | 19.2% | 16.5% | ||
| Q4 24 | 27.6% | 1.5% | ||
| Q3 24 | 6.0% | 21.0% | ||
| Q2 24 | 16.9% | 12.6% | ||
| Q1 24 | 21.0% | 14.6% |
| Q4 25 | 1.1% | 0.4% | ||
| Q3 25 | 1.8% | 0.4% | ||
| Q2 25 | 1.7% | 0.6% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 1.3% | 0.4% | ||
| Q3 24 | 3.1% | 0.4% | ||
| Q2 24 | 1.5% | 0.3% | ||
| Q1 24 | 0.9% | 0.4% |
| Q4 25 | 5.17× | -0.61× | ||
| Q3 25 | 3.32× | 3.12× | ||
| Q2 25 | 0.40× | 6.94× | ||
| Q1 25 | — | 2.84× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | 1.54× | 9.41× | ||
| Q2 24 | 3.17× | 1.47× | ||
| Q1 24 | — | 2.00× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
VIASP
| Retail Electricity | $79.7M | 62% |
| Retail Natural Gas | $48.9M | 38% |
